WeVote

Bill

Bill

HB 2194

Modifies provisions relating to epinephrine delivery devices

2026 Regular Session Introduced by Matthew Overcast and 1 co-sponsor

Missouri HB 2194 modifies epinephrine auto-injector delivery/distribution rules; passed committee with favorable recommendation pending further legislative action.

HCS Reported Do Pass (H) - AYES: 17 NOES: 0 PRESENT: 0
0
WeVote Research Nonpartisan
Bill Summary · HB 2194

Legislative bill overview

HB 2194 modifies Missouri state law governing epinephrine auto-injector (EpiPen) devices and their delivery or distribution. The bill has passed committee review with a favorable recommendation, though specific amendments made in the House Committee Substitute (HCS) are not detailed in the provided action summary.

Why is this important

Epinephrine auto-injectors are critical emergency medications for severe allergic reactions (anaphylaxis), and regulatory clarity around their availability, storage, and use can affect public health outcomes in schools, workplaces, and public spaces. Changes to epinephrine device provisions could impact access, liability protections for dispensers, or emergency preparedness protocols across the state.

Potential points of contention

  • Access vs. liability balance: Expanding access to epinephrine devices (such as keeping them in public spaces) may conflict with concerns about liability for non-medical personnel administering them
  • Scope of changes unclear: The specific modifications are not publicly detailed, making it difficult to assess whether changes align with medical best practices or create unintended consequences
  • Implementation costs: Any expansion of epinephrine availability in public facilities may impose unfunded costs on schools, businesses, or municipalities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.